Amazon-JP Morgan-Berkshire Hathaway healthcare JV named ‘Haven’

Haven is expected to serve around 1.2 million employees of the three founding companies initially

The healthcare joint venture (JV) formed in January 2018 by Amazon, Berkshire Hathaway and J.P. Morgan has reportedly been entitled as ‘Haven’. The new Boston-based company, which has recently rolled out a new website, has confirmed the opening of another office in New York.

Reportedly, Amazon’s CEO Jeff Bezos, Berkshire Hathaway’s CEO Warren Buffett and J.P. Morgan’s CEO Jamie Dimon teamed up with an aim to tackle the burgeoning health-care expenses. They founded the non-profit company and designated Dr. Atul Gawande, a noted author, speaker and surgeon, as the CEO in June.

Dr. Gawande says that the company aims to revolutionize the way healthcare is experienced by people and make it better, simpler and less expensive. He added that the company will be starting off as a small entity, learn from patients’ experiences and continue to grow to meet their requirements.

As per a report by Bloomberg Quint, the companies have depicted the JV as a long-term effort, which is free from constraints and profit-making incentives. It further reported that the venture recently got tangled in a legal dispute with the Optum unit of UnitedHealth Group Inc., which also saw a former employee named David William Smith get sued for enforcing a noncompete agreement after being hired by Haven.

Haven, with the new brand, has introduced a website known as, that contains additional details of the joint venture and certain crucial areas including the improvement of the navigation process of the complex healthcare system and making affordable prescription drugs and treatments available to patients.

Sources added that Haven is keen on working with clinicians as well as insurance companies in order to augment the overall healthcare system and further revealed that the website contains a letter in which Gawande has described the role of Haven as an advocate for patients and an ally to everyone including industry leaders, clinicians, policymakers and innovators, who improve patient care by making it cost-effective.